Responsive image

Under Auspices

International Osteoporosis Foundation


DAY I - 27.09.2019 (Friday)

S01 09.20-10.25 Supplementation in osteoporosis
Chairman: Marcinowska-Suchowierska E., Przedlacki J.
L01 Marcinowska-Suchowierska E., Płudowski P. Guidelines of vitamin D supplementation and vitamin D deficiency treatment in adult patients
L02 Misiorowski W. Vitamin K: Myth or reality?
L03 Berwecka M., Warzecha M., Amarowicz J., Czerwiński E. Does vitamin D prevent falls?
L04 Przedlacki J. Calcium supplementation and cardiovascular risk
S02 10.25-11.45 Long-term treatment of osteoporosis (Session sponsored by AMGEN)
Chairman: Czerwiński E., Sewerynek E.
L05 Czerwiński E., Borowy P. Denosumab in long-term treatment of osteoporosis
L06 Korkosz M. Denosumab and bisphosphonates
L07 Sewerynek E. How long to treat osteoporosis, use or not drug holiday?
L08 Marcinowska-Suchowierska E., Kupisz-Urbańska M. The clinical aspects of drug-drug interaction in the management of osteoporosis
L09 Głuszko P. Management of osteoporosis induced by long-term systemic treatment with glucocorticoids
11.45-12.15 Coffee break
S03 12.15-13.30 New strategies in osteoporosis treatment
Chairman: Papapoulos S., Franek E.
L10 Papapoulos S. Antifracture efficacy of sclerostin inhibitors
L11 Franek E. Abaloparatide in osteoporosis treatment
L12 Osieleniec J. Sequential therapy in osteoporosis treatment
L13 Cummings S., Lui L., Allen I., Eastell R. The effect of treatments for osteoporosis on mortality
13.30-14.30 Lunch / Poster session
A course (in Polish) organized by Norax Medical: REMS densitometry in the modern diagnosis of osteoporosis
S04 14.30-15.45 Advances in diagnostics of osteoporosis
Chairman: Kanis J, Czerwiński E.
L14 Amarowicz J., Kumorek A., Berwecka M, Warzecha M.,Czerwinski E. Use of TBS in fracture risk assessment in osteopenia
L15 Kanis J. FRAX efficacy in fracture prevention - (SCOOP)
L16 Leszczyński P. Vertebral Fracture Assessment in the diagnosis of asymptomatic spinal fractures
L17 Iwaszkiewicz C., Leszczyński P. Bone densitometry by radiofrequency echographic multi-spectrometry (REMS) in the diagnosis of osteoporosis
L18 Nowakowska-Plaza A., Głuszko P. Comparative analysis of diagnostic methods of osteoporosis using traditional densitometry and REMS system - sonographic technique using radiofrequency
15.45-16.15 Coffee break
S05 16.15-17.35 Complications in osteoporosis treatment
Chairman: Pluskiewicz W., Kucharz E.
L19 Pluskiewicz W. Bisphosphonates - indications (SPC) and contraindications
L20 Czerwiński E., Warzecha M., Borowy P. Atypical fractures - diagnosis and treatment
L21 Wyszyńska-Pawelec G. Prevention of medication-related osteonecrosis of the jaws
L22 Jabłoński M. Treatment of vertebral fractures
L23 Żyluk A. Complex Regional Pain Syndrome (algodystrophy, Sudeck’s syndrome)
S06 17.35-18.35 Round-table discussion: Problems related to treatment of osteoporosis in Poland
Chairman: Czerwiński E., Sawicki A.
Participants: Batko B., Marcinowska-Suchowierska E., Serwerynek E.

DAY II- 28.09.2019 (Saturday)

S07 08.00-9.40 Osteoporosis - not only postmenopausal
Chairman: Misiorowski W., Korkosz M.
L24 Franek E. Diagnostic algorithm of osteoporosis in endocrine diseases
L25 Misiorowski W. Osteoporosis in the aging male
L26 Więcek A. Management in chronic kidney disease - mineral and bone disorder (CKD-MBD)
L27 Kalinka E. Osteoporosis in the course of pharmacotherapy of breast and prostate cancer
L28 Osieleniec J. Osteoporosis in systemic connective tissue diseases
L29 Nawrat-Szołtysik A. Opara J., Miodońska Z., Adamczuk E., Matyja B., Polak A. Quality of life of elderly men with osteoporosis
09.40-10.10 Coffee break
S8 10.10-11.45 Advances in the treatment of osteoarthritis
Chairman: Reginster J-Y., Jaworek J.
L30 Reginster J-Y. Advances in the treatment of osteoarthritis
L31 Białoszewski D. Preparations given in intra-articular injections in the treatment of osteoarthritis - do they actually cure?
L32 Woroń J. Treatment of pain in osteoarthritis
L33 Badurski J. Musculoskeletal manifestations of hyperparathyroidism
L34 Jaworek J. Role of physiotherapy in prophylactic and therapy of osteoarthrosis
S9 11.45-13.00 Aging and sarcopenia
Chairman: Grodzicki T., Povoroznyuk V.
L35 Grodzicki T. Healthy aging
L36 Berwecka M., Warzecha M. The most recent definition of sarcopenia
L37 Povoroznyuk V. Sarcopenia - prevention and treatment
L38> Warzecha M., Berwecka M., Amarowicz J., Czerwinski E. Falls risk assessment, strength, gait speed, muscle mass
13.00-14.00 LUNCH
S10 14.00-15.30 The increase of the untreated – possible interventions
Chairman: Brzosko M., Głuszko P.
L39 Brzosko M. Current status of osteoporosis treatment in Poland
L40 Glinkowski W., Narloch J., Krasuski K., Śliwczyński A. Mortality after proximal femur fracture in Poland
L41 Czerwiński E., Borowy P., Amarowicz J. Why does the number of the non-treated osteoporosis patients increase in Poland?
L42 Amarowicz J., Czerwiński E. Kumorek A. Importance of FLS in fracture prevention
L43 Głuszko P. Polish program for the coordination of osteoporotic fracture prevention POWER
S11 15.30-17.15 Miscellaneous
Chairman: Lorenc R., Konstantynowicz J.
L44 Palicka V. Role of genetics in fracture risk prediction
L45 Konstantynowicz J., Abramowicz P., Stawicki K. Osteogenesis imperfecta in adults: a brief overview and current challenges
L46 Lorenc R. Position of Bone Turnover Markers (BTM) in Diagnostic and Treatment of Osteoporosis
L47 Borowy P. Bone metabolism disorders in rare diseases
L48 Kucharz E. Osseous involvement in patients with sarcoidosis
L49 Berwecka M. Czerwinski E,. Amarowicz J., Warzecha M., Kumorek A. FRAX and TBS in fracture risk assessment
17.15 Closing ceremony



Polish Osteoarthrology Society

European Foundation of Osteoporosis and Musculoskeletal Diseases

Polish Osteoporosis Foundation

Department of Bone and Joint Diseases UJ CM